QuintilesIMS is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhanced clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.
QuintilesIMS Consulting is a subsidiary focused on providing strategic advisory to clients in the healthcare industry, including pharmaceuticals producers, distributors, pharmacy chains, healthcare services providers, payers and government agencies. The company combines strategic consulting and pharma industry expertise with unique data assets to provide its clients with support in designing development strategies as well as improving sales and marketing efficiency.